<DOC>
	<DOCNO>NCT02897466</DOCNO>
	<brief_summary>Inappropriate antibiotic therapy ventilator-associated pneumonia ( VAP ) associate increased mortality . The international guideline recommend use broad spectrum antimicrobial especially patient receive previous antimicrobial , risk factor muti-drug resistant ( MDR ) VAP 5 day mechanical ventilation . Using broad-spectrum antibiotic 48h result conventional culture antimicrobial susceptibility testing ( AST ) available , may promote emergence drug-resistant bacteria . Exposure imipenem , short 1 3 day , associate 5-fold increase risk imipenem resistance gut microbiota ICU patient ( Armand-Lefevre AAC 2013 ) . Performing AST directly clinical respiratory sample would hasten process least 24h . The diagnostic performance rapid method combine mass spectrometry direct AST [ DAST ] previously analyze , compare conventional method ( mass spectrometry conventional AST [ CAST ] ) potential impact assess antimicrobial use 85 patient ( Le DORZE M et al - Clin . Microbiol . Infect . 2015 ) . The result produce dast useable 85,9 % case sensitivity negative predictive value DAST 100 % antibiotic test , except gentamicin ( 97.1 % [ 95 % CI = 93.3-101 ] 97.4 % [ 93.7-101 ] , respectively ) amikacin ( 88.9 % [ 81.7-96.1 ] 96.4 % [ 92.1-100.7 ] , respectively ) , compare CAST . Specificity positive predictive value range 82.9 ( 74.2-91.5 ) 100 % , 86.4 ( 78.5−94.2 ) 100 % , respectively . If result report clinician , DAST would save carbapenem prescription 17 case ( 22 % ) would allow immediate narrow spectrum antimicrobial 35/85 ( 41.2 % ) case . But , benefit DAST base simulation test randomized fashion . This project prospective multicenter study . The hypothesis , DAST compare CAST , would increase number adequate antimicrobial therapy within 24 hour case late VAP ( &gt; 5 day mechanical ventilation ) Gram negative bacillus ( GNB ) IC patient spar carbapenems ( imipenem meropenem ) . The primary objective determine impact strategy use DAST rate day1 adequate therapy without carbapenems case late VAP due GNB .</brief_summary>
	<brief_title>Impact Direct Antimicrobial Susceptibility Testing Respiratory Sample Intensive Care Patient With Suspected VAP</brief_title>
	<detailed_description>Inappropriate antibiotic therapy ventilator-associated pneumonia ( VAP ) associate increased mortality . The international guideline recommend use broad spectrum antimicrobial especially patient receive previous antimicrobial , risk factor muti-drug resistant ( MDR ) VAP 5 day mechanical ventilation . Using broad-spectrum antibiotic 48h result conventional culture antimicrobial susceptibility testing ( AST ) available , may promote emergence drug-resistant bacteria . Exposure imipenem , short 1 3 day , associate 5-fold increase risk imipenem resistance gut microbiota ICU patient ( Armand-Lefevre AAC 2013 ) . Performing AST directly clinical respiratory sample would hasten process least 24h . The diagnostic performance rapid method combine mass spectrometry direct AST [ DAST ] , previously analyze compare conventional method ( mass spectrometry conventional AST [ CAST ] ) potential impact assess antimicrobial use 85 patient ( Le DORZE M et al - ICAAC 2013 , clinical microbiology infection submit ) . The result produce dast useable 85,9 % case sensitivity negative predictive value DAST 100 % antibiotic test , except gentamicin ( 97.1 % [ 95 % CI = 93.3-101 ] 97.4 % [ 93.7-101 ] , respectively ) amikacin ( 88.9 % [ 81.7-96.1 ] 96.4 % [ 92.1-100.7 ] , respectively ) , compare CAST . Specificity positive predictive value range 82.9 ( 74.2-91.5 ) 100 % , 86.4 ( 78.5−94.2 ) 100 % , respectively . If result report clinician , DAST would save carbapenem prescription 17 case ( 22 % ) would allow immediate narrow spectrum antimicrobial 35/85 ( 41.2 % ) case . But , benefit DAST base simulation test randomized fashion . Hypothesis - DAST compare CAST , would increase number adequate antimicrobial therapy within 24 hour case late VAP ( &gt; 5 day mechanical ventilation ) Gram negative bacillus ( GNB ) ICUs spar carbapenems ( imipenem meropenem ) . Primary objective - To determine impact strategy use DAST rate day1 adequate therapy spar carbapenems case late VAP due GNB . Secondary objective : 1 . To evaluate impact DAST strategy compare CAST follow outcome : - Adequate antimicrobial therapy Day1 ( without carbapenem ) - exposure carbapenems D14 D28 - Broad spectrum antibiotic exposure D14 D28 - De-escalation D1 - relapse new VAP D14 D28 . - emergence ESBL produce GNB / resistant broad-spectrum antibiotic clinical sample intestinal microbiota D3 , D7 , D14 D28 , discharge ICU patient - Changes respiratory infection organ failure - Mechanical ventilation exposure day 1 28 - Length ICU stay . - In-ICU mortality . 2 . To evaluate performance diagnostic DAST compare CAST 3 . To achieve minimization study cost DAST strategy compare CAST strategy Experimental scheme procedure This study multicentre , prospective , parallel-group , open-label trial . After baseline screening , independent , centralized , computer-generated randomization sequence use randomly assign patient 1:1 ratio DAST CAST group . Random allocation stratify centre ; investigator mask assignment , , randomization , per open-label design . This system password protect access principal investigator study coordinator patient surrogate give consent meet inclusion criterion . Although treatment assignment mask , investigator unaware aggregate outcome study . Number patient According preliminary study , 76 patient could enrol within one year 3 ICUs half receive carbapenems initially . DAST would permit spare carbapenems 22 % case avoid inadequate penem use 5 percent case . The expected proportion adequate antibiotic therapy without carbapenem 68 % . In , 68 patient per arm necessary detect 22 % difference group power 90 % ( pooled variance Z test ) . The level significance 5 % . The hypothesis 15 % DAST non-contributive 5 % patient lose follow , 90 patient per arm ( 140 patient overall ) need enroll . According previous number preliminary study , 180 patient enrol within 18 month inclusion . Inclusions - 180 patient enrol 18 month period In , 9 investigation center associate study . Thus , around 1.1 patient need enrol per month 18 month center Statistical analyse - Both group compare Cochrane Mantel HAENTZEL chi square primary end point . Other secondary objective require model longitudinal data , model censor data account compete event ( MDR acquisition , day 28 outcome ) . The random unit patient . The first episode take account primary end point . In case repeat VAP GNB , sample proceed accord random allocation arm ( CAST DAST ) day 28 ICU discharge . Data collect definition : After obtain appropriate respiratory specimen Gram stain conventional culture , initial antibiotic therapy ( day 0 ) give accord standard care , agreement international guideline : Initial Empiric Antibiotic Therapy patient late-Onset Disease risk factor MDR pathogens ATS IDSA 2005 ( table 1-2-3 ) avoid carbapenem whenever possible . The following data collect : At admission ICU : age , sex , pre-existing comorbidities , previous location admission , admission category , reason admission , SAPS II , presence type organ dysfunction use sequential organ-failure assessment ( SOFA ) score , use mechanical ventilation . Between D1 D3 : Microbiological result VAP episode ( GNB identification , CAST DAST ) Between D1 D28 All infection occur colonization MDR SOFA score type organ system failure CPIS score ( D1,2,3,7,14,28 ) All antibiotic exposure . Adequacy initial empirical antibiotic regimen VAP suspect due gram negative organism inclusion record . Inadequate antimicrobial treatment define use antibiotic least one cultured isolate resistant vitro day 1 . Besides initial respiratory specimen inclusion , microbiological assessment specimens take day 0 = inclusion day 14 record . Multidrug-resistant bacteria define accord MAGIORAKOS Clin Microbiol infect , 2012 . Broad spectrum antimicrobial define antibiotic belong rank 4 6 ( Piperacillin+Tazobactam , Ticarcillin+Clavulanic Acid 4th generation cephalosporin , Antipseudomonal 3rd generation cephalosporin , Carbapenems ) ( Weiss et al , Clin . MICROB . Infect . 2015 ) . For purpose study , de-escalation consider pivotal antibiotic switch antibiotic narrower spectrum empirical treatment , accord ranking molecule recent study perform behalf `` '' de-escalation '' '' study ( Weiss et al , Clin . MICROB . Infect . 2015 ) ''</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Disease Susceptibility</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Adults ( 18 year old ) Need mechanical ventilation expect least 5 day time ICU stay ( include intubation perform ICU admission ) VAP suspect clinical respiratory sample GNB direct smear examination At least one condition risk factor multidrug resistant infection : 1 . Previous use antimicrobial ( least 2 day past 7 day ) 2 . Risk colonization infection MDR XDR bacteria within 3 month Written inform consent obtain patient surrogate . The patient surrogate withdraw study time . Pregnant lactate woman VAP suspect respiratory sample without GNB direct smear examination VAP occur without neither previous antimicrobial exposure past 5 day neither risk MDR colonization Samples send lab night weekend center respiratory sample perform period Active therapeutic limitation Known allergy antibiotic Social welfare unavailable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>ventilator-associated pneumonia</keyword>
	<keyword>Multidrug-resistant bacteria</keyword>
</DOC>